ArticleJACC. Cardiovascular imaging2018

Using Trial Eligibility to Personalize Statin Therapy Appears No More Accurate Than a Coin Flip in Determining High-Risk Status.

Roger S Blumenthal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.